Regulation Networks Driving Vasculogenic Mimicry in Solid Tumors

Area of Science:

• Oncology
• Molecular Biology
• Cancer Research

Background:

• Vasculogenic mimicry (VM) describes cancer cells forming vascular networks, independent of endothelial cells, supplying aggressive tumors.
• VM is linked to chemotherapy resistance, poor survival, and adverse prognosis in various solid malignancies.
• Aberrant expression of microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) is implicated in cancer progression.

Purpose of the Study:

• To review the mechanisms of VM, its association with the tumor microenvironment and epithelial-mesenchymal transition.
• To explore the regulatory roles of miRNAs and lncRNAs in VM.
• To discuss the clinical implications of these non-coding RNAs as biomarkers for diagnosis and therapy.

Main Methods:

• Literature review of studies on vasculogenic mimicry.
• Analysis of the role of non-coding RNAs (miRNAs, lncRNAs) in cancer vascularization.
• Examination of tumor microenvironment and epithelial-mesenchymal transition in VM.

Main Results:

• VM is a significant factor in aggressive cancers, promoting nutrient/oxygen supply and therapy resistance.
• miRNAs and lncRNAs are key regulators of VM, influencing gene expression post-transcriptionally.
• Dysregulated lncRNA-miRNA interactions are implicated in VM development and cancer aggressiveness.

Conclusions:

• Understanding VM regulation by non-coding RNAs is crucial for developing novel cancer biomarkers and therapeutics.
• Targeting VM-related lncRNA-miRNA networks may offer new strategies for treating aggressive, therapy-resistant cancers.
• VM-associated non-coding RNAs hold promise for improving cancer diagnosis, prognosis, and treatment response prediction.